COVID19 pandemic: An overview of its origin, current status and ongoing clinical trials

Author:

Majila Kartik1,Lal Seema2,Ahmad Mohammad Faiz1ORCID

Affiliation:

1. School of Biotechnology, Jawaharlal Nehru University, New Delhi-110067, India

2. Department of Chemistry, Deshbandhu College, Delhi University, New Delhi-110019, India

Abstract

: The COVID19 pandemic is raging across the globe with the total active cases increasing each day. Globally over 63 million COVID-19cases and more than 1.4 million deaths have been reported to WHO. Throughout the world academicians, clinicians and scientists are working tirelessly on developing treatment to combat this pandemic. Origin of novel SARS-COV-2 virus still remain foggy but is believed to have originated from a bat coronavirus RaTG13 with which it shares approximately 96% sequence similarity. In the present review, authors have provide an overview of the COVID-19 pandemic, epidemiology, transmission, developments related to diagnosis, drugs and vaccines along with the genetic diversity and lifecycle of the SARS CoV2 based on the current studies and information available.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Complementary and alternative medicine,Pharmaceutical Science

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3